Total Payments
$2,570
2024 Payments
$67.13
Companies
25
Transactions
60
Medicare Patients
5,303
Medicare Billing
$470,334
Payment Breakdown by Category
Travel$1,313 (51.1%)
Food & Beverage$982.65 (38.2%)
Education$273.80 (10.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,313 | 1 | 51.1% |
| Food and Beverage | $982.65 | 54 | 38.2% |
| Education | $273.80 | 5 | 10.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valencia Technologies Corporation | $1,313 | 1 | $0 (2022) |
| Astellas Pharma US Inc | $358.89 | 12 | $0 (2021) |
| Lilly USA, LLC | $122.09 | 1 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $93.47 | 6 | $0 (2018) |
| TOLMAR Pharmaceuticals, Inc. | $81.26 | 5 | $0 (2019) |
| Teleflex LLC | $69.84 | 3 | $0 (2024) |
| Tolmar, Inc. | $55.00 | 2 | $0 (2023) |
| Boston Scientific Corporation | $51.54 | 3 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $50.23 | 3 | $0 (2018) |
| Allergan, Inc. | $48.42 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.13 | 2 | Teleflex LLC ($40.38) |
| 2023 | $89.35 | 4 | Tolmar, Inc. ($55.00) |
| 2022 | $1,452 | 3 | Valencia Technologies Corporation ($1,313) |
| 2021 | $148.63 | 4 | Astellas Pharma US Inc ($116.74) |
| 2020 | $30.58 | 2 | Allergan, Inc. ($16.38) |
| 2019 | $104.58 | 5 | Astellas Pharma US Inc ($67.51) |
| 2018 | $327.78 | 20 | Bayer HealthCare Pharmaceuticals Inc. ($68.49) |
| 2017 | $350.15 | 20 | Astellas Pharma US Inc ($133.89) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $40.38 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 02/09/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $26.75 | General |
| 09/12/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Interventional Urology | ||||||
| 07/03/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Urology | ||||||
| 06/29/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Prostate Cancer | ||||||
| 05/09/2023 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Prostate Cancer | ||||||
| 11/17/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $122.09 | General |
| Category: Diabetes | ||||||
| 06/24/2022 | Valencia Technologies Corporation | eCoin Device Kit (Device) | Travel and Lodging | Cash or cash equivalent | $1,313.35 | General |
| Category: Treat Urgency Urinary Incontinence | ||||||
| 05/10/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Interventional Urology | ||||||
| 06/24/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 03/23/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: HORMONE THERAPY | ||||||
| 03/11/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: UROLOGY | ||||||
| 02/03/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 10/23/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: UROLOGY | ||||||
| 02/20/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Interventional Urology | ||||||
| 06/25/2019 | Boston Scientific Corporation | GENERAL ONCOLOGY (Device) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: GENERAL | ||||||
| 05/01/2019 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: Prostate Cancer | ||||||
| 04/16/2019 | Boston Scientific Corporation | GENERAL ONCOLOGY (Device) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: GENERAL | ||||||
| 04/04/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $15.52 | General |
| Category: ONCOLOGY | ||||||
| 01/02/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $51.99 | General |
| 12/06/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: UROLOGY | ||||||
| 10/23/2018 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diagnostic Imaging | ||||||
| 08/30/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Endocrinology | ||||||
| 08/21/2018 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Oncology | ||||||
| 08/13/2018 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,106 | 1,704 | $270,186 | $95,534 |
| 2022 | 19 | 1,261 | 1,905 | $301,910 | $109,291 |
| 2021 | 18 | 1,365 | 2,028 | $360,293 | $131,773 |
| 2020 | 18 | 1,571 | 2,236 | $374,635 | $133,735 |
Total Patients
5,303
Total Services
7,873
Medicare Billing
$470,334
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 363 | 491 | $87,398 | $28,776 | 32.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 21 | 198 | $55,440 | $26,597 | 48.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 90 | 108 | $46,332 | $18,891 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 100 | $25,100 | $8,817 | 35.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $9,386 | $2,962 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $8,648 | $2,533 | 29.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $4,680 | $1,329 | 28.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 300 | 487 | $2,922 | $1,070 | 36.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 96 | 139 | $5,143 | $996.76 | 19.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 21 | 36 | $2,412 | $856.35 | 35.5% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 12 | 16 | $2,976 | $854.35 | 28.7% |
| 55899 | Other procedure on male genital system | Office | 2023 | 14 | 14 | $10,668 | $850.46 | 8.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 12 | 16 | $2,464 | $616.84 | 25.0% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 13 | 13 | $5,213 | $323.31 | 6.2% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 12 | 12 | $1,404 | $62.39 | 4.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 379 | 523 | $89,611 | $31,125 | 34.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 23 | 204 | $57,120 | $29,074 | 50.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 95 | 118 | $50,622 | $20,080 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 96 | $22,986 | $8,431 | 36.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 53 | 53 | $13,091 | $4,052 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $13,912 | $3,910 | 28.1% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 17 | 44 | $6,776 | $2,030 | 30.0% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 16 | 16 | $5,232 | $1,639 | 31.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 12 | 14 | $7,497 | $1,417 | 18.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2022 | 19 | 24 | $4,464 | $1,394 | 31.2% |
About Dr. Michael Kane, M.D
Dr. Michael Kane, M.D is a Urology healthcare provider based in Westminster, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710918057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Kane, M.D has received a total of $2,570 in payments from pharmaceutical and medical device companies, with $67.13 received in 2024. These payments were reported across 60 transactions from 25 companies. The most common payment nature is "Travel and Lodging" ($1,313).
As a Medicare-enrolled provider, Kane has provided services to 5,303 Medicare beneficiaries, totaling 7,873 services with total Medicare billing of $470,334. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Westminster, MD
- Active Since 07/05/2006
- Last Updated 10/11/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710918057
Products in Payments
- eCoin Device Kit (Device) $1,313
- ELIGARD (Drug) $136.26
- MOUNJARO (Drug) $122.09
- Xofigo (Drug) $93.47
- UROLIFT (Device) $69.84
- MYRBETRIQ (Drug) $45.66
- TESTOPEL (Drug) $38.17
- Myrbetriq (Drug) $33.59
- Erleada (Drug) $30.24
- XTANDI (Drug) $27.40
- TOVIAZ (Drug) $26.91
- GENERAL ONCOLOGY (Device) $26.13
- OBTRYX (Device) $25.41
- INVOKANA (Drug) $24.38
- Axonics (Device) $21.05
- Axumin (Drug) $20.13
- NAMZARIC (Drug) $18.61
- Prolaris (Device) $18.40
- FARXIGA (Drug) $17.67
- BOTOX (Biological) $16.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Westminster
Dr. Michael Davenport, Md, MD
Urology — Payments: $56,404
Urology $56,404
Dr. Robert Segal, M.d, M.D
Urology — Payments: $25,217
Urology $25,217
Michael Ferrandino, Md, MD
Urology — Payments: $23,444
Urology $23,444
Brian Levin, M.d, M.D
Urology — Payments: $7,439
Urology $7,439
Dr. Keith Oreilly, M.d, M.D
Urology — Payments: $6,873
Urology $6,873
Dr. Jordan Angell, Md, MD
Urology — Payments: $5,826
Urology $5,826